News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR researcher wins major prize at 2017 San Antonio Breast Cancer Symposium
An ICR researcher has been given a prestigious award at the San Antonio Breast Cancer Symposium, one of the world’s most important annual breast cancer research conferences.
Breast, bowel and other cancers could be targeted by new drug type
Drugs that target a ‘crutch’ used by cancer cells to keep on dividing and growing could help treat a range of cancer types, researchers have found.
ICR joins call to ensure continued recruitment of technical scientists after Brexit
The Institute of Cancer Research has joined other influential UK research and higher education bodies to call for government recognition of the importance of international technicians in delivering world-leading research.
ICR awarded major prize for pioneering discoveries in precision medicines for cancer
The Institute of Cancer Research, London, has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Genetic link found between the immune system and lymphoma
People who inherit genetic changes which alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, a major new study reports.
Local MP scanned as healthy volunteer in pioneering new MR Linac radiotherapy machine
MP for Sutton and Cheam Paul Scully has volunteered to be scanned as part of research to help develop a revolutionary new type of radiotherapy machine. He is one of the first healthy volunteers to be scanned as part of the initial trials of the MR Linac.
European Medicines Agency approves abiraterone combined with hormone therapy as first-line treatment for advanced prostate cancer
The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.
Smoking – particularly if started during adolescence – is associated with an increased risk of breast cancer, major new study finds
A major new prospective study funded by Breast Cancer Now has found that smoking is associated with an increased risk of breast cancer, particularly among those who began smoking during adolescence and those with a family history of the disease.
ICR fundraisers take part in Climb of Life 30th year celebrations to raise a new record-breaking total
The 30th Climb of Life annual fundraiser has celebrated a landmark year – with an amazing total of over £900,000 raised for the ICR over the lifetime of the event.
Our world-leading prostate cancer research
Researchers at the ICR are known around the world for their success in improving treatments for men with prostate cancer. Henry French gives an overview of some of our more recent discoveries.
ICR responds to NICE approval of new breakthrough drugs on the NHS for women with advanced breast cancer
The Institute of Cancer Research, London, welcomes the approval by NICE of a new type of treatment for women with previously untreated advanced breast cancer.
MR Linac: first healthy volunteer scanned in pioneering new radiotherapy machine
The first healthy volunteer has been scanned using a revolutionary new type of radiotherapy machine, which is set to transform cancer treatment by allowing radiation to be aimed at tumours with extreme precision.
